Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Onsrud

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
International Journal of Cancer|April 13, 2000
Report on consensus conference on cervical cancer screening and managementA B Miller, S Nazeer, S Fonn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrumentC Tropé, J Kaern, T Hogberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experienceC Tropé, T Hogberg, J Kaern, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
International Journal of Cancer|April 13, 2000
Report on consensus conference on cervical cancer screening and managementA B Miller, S Nazeer, S Fonn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrumentC Tropé, J Kaern, T Hogberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experienceC Tropé, T Hogberg, J Kaern, et al.
Pageof 8